WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018017775) METHODS OF ATTENUATING DRUG EXCIPIENT CROSS REACTIVITY
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/017775 International Application No.: PCT/US2017/042947
Publication Date: 25.01.2018 International Filing Date: 19.07.2017
IPC:
A61K 47/32 (2006.01) ,A61K 47/58 (2017.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
30
Macromolecular compounds
32
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
[IPC code unknown for A61K 47/58]
Applicants: CHESAPEAKE THERAPEUTICS, LLC[US/US]; 1498-m Reisterstown Road Suite 313 Pikesville, MD 21208, US
Inventors: LAWRENCE, Robb; US
BAKIN, Robert, E.; US
Agent: NEVRIVY, Daniel, J.; US
Priority Data:
62/364,43820.07.2016US
62/602,13213.04.2017US
Title (EN) METHODS OF ATTENUATING DRUG EXCIPIENT CROSS REACTIVITY
(FR) PROCÉDÉS D'ATTÉNUATION DE LA RÉACTIVITÉ CROISÉE D'UN EXCIPIENT DE MÉDICAMENT
Abstract:
(EN) The present application relates generally to novel pharmaceutical drug formulations comprising modified chemical compositions having reduced capacity for excipient mediated cross reactivity. Methods for their use and methods for identifying excipient related incompatibilities and/or adverse events are also disclosed.
(FR) La présente invention concerne de manière générale de nouvelles formulations pharmaceutiques de médicaments comprenant des compositions chimiques modifiées ayant une capacité réduite de réactivité croisée médiée par l'excipient. Des méthodes pour leur utilisation et des méthodes pour identifier des événements indésirables et/ou des incompatibilités liées à l'excipient sont divulguées.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)